Therefore, the tumorigenic effects of COL11A1 and LRRK2 overexpression and antitumorigenic effects of PPARGC1A and ITPR1 overexpression in ThyC in our study were consistent with previous studies. The gene discussed is PPARGC1A; the disease is thymic carcinoma.